|
MechanismHSP90B inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Qingdao Taiboheng Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Qingdao Taiboheng Biomedical Technology Co., Ltd.
100 Deals associated with Qingdao Taiboheng Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Qingdao Taiboheng Biomedical Technology Co., Ltd.